Microbiology, immune & preclinical mechanisms
Biological studies of the activity of Manuka honey against Carbapenem-resistant Enterobacterales (CRE) bacteria.
Authors: Bukhari MA et al.
ARCHIVE NOTICE
A full-text editorial assessment has not yet been completed. This record preserves bibliographic and tested-material context only; consult the primary source for methods and results. No product, health or treatment claim is made.
Result handling
Consult the cited publication for the reported result. This archive does not interpret it as a product, health or treatment claim.
Study design
In-vitro antibacterial study using carbapenem-resistant Enterobacterales isolates
Antibacterial activity and biofilms
Tested material
UMF 15+ Manuka honey tested against 20 carbapenem-resistant Enterobacterales isolates using well-diffusion and minimum bactericidal concentration assays; not The 3 Beez retail product.
Limitations
Findings are limited to the tested bacterial isolates, honey preparation and laboratory assays. They do not establish effectiveness or safety in patients.
Funding & conflicts
Not yet transcribed from the primary publication.
Applicability guardrail
Manuka Drops Limited did not conduct or sponsor this work. It did not test The 3 Beez retail product unless the original source explicitly says so. This is research context, not treatment advice.
Scientific reference
Bukhari MA et al. (2024). Biological studies of the activity of Manuka honey against Carbapenem-resistant Enterobacterales (CRE) bacteria.. Saudi medical journal. https://doi.org/10.15537/smj.2024.45.9.20240153
Editorial record
Responsible publisher: Manuka Drops Limited. Record updated: 2026-09-16. Retraction check recorded: 2026-08-16. Retraction status: checked-no-retraction-signal. Editorial status: pending. Read the methodology.
Limited methods check: Publication abstract methods, 2026-09-16. This checks study design and tested material only; it is not a complete editorial or retraction review.